-
-
-
-
-
-
-
Entrada Therapeutics, Inc. (TRDA) Misses Q2 EPS by 22c
-
-
-
-
-
-
-
Entrada Therapeutics Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Entrada Therapeutics Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Entrada Therapeutics Reports Second Quarter 2022 Financial Results
-
-
-
-
-
-
-
Entrada Therapeutics (TRDA) Reports Q3 Net Loss of $14.4M, Cash and Cash Equivalents of $122.2M
-
-
1,199,645 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

